SUBSCRIBE
SUBSCRIBE

Asia

Policy
Biopharma Update on the Novel Coronavirus: September 25
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
September 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 23
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
September 22, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
150+ Nations Join WHO Effort to Fairly Distribute COVID-19 Vaccine Across the Globe
More than 150 countries have signed on to a World Health Organization program to ensure global access to a COVID-19 vaccine, however, the United States, Russia and China refrained from signing the agreement.
September 22, 2020
 · 
3 min read
 · 
Alex Keown
Policy
Legend Biotech Names Interim CEO Amid Investigation by Chinese Government
Legend’s CEO and Board Chairman, Fangliang “Frank” Zhange, was placed on “residential surveillance” by PRC law enforcement.
September 21, 2020
 · 
3 min read
 · 
Kate Goodwin
Policy
Biopharma Update on the Novel Coronavirus: September 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 21, 2020.
September 21, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
BioCapital
ESMO News: AstraZeneca, Merck, Janssen, Amgen and More
The European Society for Medical Oncology (ESMO) Virtual Congress 2020 was this weekend, with numerous companies presenting clinical trial data and updates.
September 21, 2020
 · 
4 min read
 · 
Mark Terry
BioForest
Clinical Catch-Up: September 14-18
It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies.
September 18, 2020
 · 
11 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, Sept. 18
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
September 17, 2020
 · 
11 min read
 · 
Alex Keown
Drug Development
Biopharma Update on the Novel Coronavirus: September 18
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 18, 2020.
September 17, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
BioSpace Global Roundup, Sept. 17
Companies from across the globe provide updates on their businesses and pipelines.
September 16, 2020
 · 
5 min read
 · 
Alex Keown
Load More
PRESS RELEASES
Press Releases
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency
February 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
February 19, 2026
 · 
10 min read
Press Releases
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
February 18, 2026
 · 
6 min read
Press Releases
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases
February 18, 2026
 · 
3 min read
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
 · 
3 min read
Press Releases
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
February 18, 2026
 · 
6 min read
Press Releases
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
February 18, 2026
 · 
8 min read
Press Releases
Adagene to Participate in Two Upcoming Investor Conferences - February 17, 2026
February 17, 2026
 · 
3 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
 · 
5 min read
Press Releases
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
February 17, 2026
 · 
6 min read
Press Releases
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
February 16, 2026
 · 
5 min read
Press Releases
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday
February 16, 2026
 · 
7 min read
Press Releases
CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
February 16, 2026
 · 
4 min read
Press Releases
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
February 13, 2026
 · 
5 min read
Press Releases
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
 · 
5 min read
Press Releases
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
February 13, 2026
 · 
7 min read
Press Releases
World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
February 13, 2026
 · 
5 min read
Press Releases
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
February 13, 2026
 · 
12 min read
Press Releases
HanchorBio Receives FDA Orphan Drug Designation for HCB101 in Gastric Cancer
February 13, 2026
 · 
5 min read
Press Releases
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
February 12, 2026
 · 
2 min read
Load More